Want to be the first to know about updates for #GCOS27? Join our mailing list 👇
tinyurl.com/3pzcm287
#GCOS27 #CardioOncology #CardioOnc #Tokyo #Japan #CardioOncologyConference #HealthcareConference
Want to be the first to know about updates for #GCOS27? Join our mailing list 👇
tinyurl.com/3pzcm287
#GCOS27 #CardioOncology #CardioOnc #Tokyo #Japan #CardioOncologyConference #HealthcareConference
Today: exercise and cardio-oncology, amyloidosis, and limiting cardiotoxicity. See you in the Virginia Room at 8:00 AM.
📰 gcos.ic-os.org/GCOS26Program
#CardioOncology #CardioOnc #Amyloidosis
Today: exercise and cardio-oncology, amyloidosis, and limiting cardiotoxicity. See you in the Virginia Room at 8:00 AM.
📰 gcos.ic-os.org/GCOS26Program
#CardioOncology #CardioOnc #Amyloidosis
Our second amyloidosis session on the latest treatments, then a conversation on cardiotoxicity from new-generation cancer therapies. Lunch follows, with the product theatre sponsored by @Alnylam 🍽️
#CardioOncology #CardioOnc #Amyloidosis
Our second amyloidosis session on the latest treatments, then a conversation on cardiotoxicity from new-generation cancer therapies. Lunch follows, with the product theatre sponsored by @Alnylam 🍽️
#CardioOncology #CardioOnc #Amyloidosis
Who takes home the silverware and the title of cardio-oncology knowledge champs? Then we explore the cardiovascular challenges facing cancer survivors post-treatment.
📰 gcos.ic-os.org/GCOS26Program
#CardioOncology #CardioOnc
Who takes home the silverware and the title of cardio-oncology knowledge champs? Then we explore the cardiovascular challenges facing cancer survivors post-treatment.
📰 gcos.ic-os.org/GCOS26Program
#CardioOncology #CardioOnc
#GCOS26 #GCOS2026 #GCOS #ThomasForce #ThomasForceAward #CardioOncology #CardioOnc #CancerCare #CancerTreatment
#GCOS26 #GCOS2026 #GCOS #ThomasForce #ThomasForceAward #CardioOncology #CardioOnc #CancerCare #CancerTreatment
📊 IC-OS leaders on the year's progress
🏅 Our newest IC-OS Hall of Fame inductee
🌟 The Young Investigator Awards
#CardioOncology #CardioOnc
📊 IC-OS leaders on the year's progress
🏅 Our newest IC-OS Hall of Fame inductee
🌟 The Young Investigator Awards
#CardioOncology #CardioOnc
Afternoon at #GCOS26 starts with our first Amyloidosis session on diagnosis and clinical case studies.
Then, 2026 #ThomasForceAward winner Dr. Alex Lyon 🇬🇧 presents "Ten Laws of Cardio-Oncology."
📰 gcos.ic-os.org/GCOS26Program
#CardioOncology #CardioOnc #Amyloidosis
Afternoon at #GCOS26 starts with our first Amyloidosis session on diagnosis and clinical case studies.
Then, 2026 #ThomasForceAward winner Dr. Alex Lyon 🇬🇧 presents "Ten Laws of Cardio-Oncology."
📰 gcos.ic-os.org/GCOS26Program
#CardioOncology #CardioOnc #Amyloidosis
But we're not through yet – join us for our poster session, followed by dinner in the Colony Room (tickets required). 🍽️
#GCOS26 #CardioOncology #CardioOnc #CardioOncologyConference #WilliamsburgVA
But we're not through yet – join us for our poster session, followed by dinner in the Colony Room (tickets required). 🍽️
#GCOS26 #CardioOncology #CardioOnc #CardioOncologyConference #WilliamsburgVA
Honored to have Cardio-Oncology titans Charles Porter, MD 🇺🇸, Daniela Cardinale 🇮🇹, and Joseph Carver 🇺🇸 with us today at #GCOS2026
#GCOS26 #CardioOncology #CardioOnc
Honored to have Cardio-Oncology titans Charles Porter, MD 🇺🇸, Daniela Cardinale 🇮🇹, and Joseph Carver 🇺🇸 with us today at #GCOS2026
#GCOS26 #CardioOncology #CardioOnc
Cardio-oncology patient Tara Daudani is here with us today to share her perspective on how cardio-oncology has impacted her life.
Thank you Tara for sharing your story!
#GCOS #CardioOnc #CardioOncology
Cardio-oncology patient Tara Daudani is here with us today to share her perspective on how cardio-oncology has impacted her life.
Thank you Tara for sharing your story!
#GCOS #CardioOnc #CardioOncology
A full day of global insights and networking starts at 8am sharp. Grab a coffee and get acquainted with the schedule 👇
📰 gcos.ic-os.org/GCOS26Program
#CardioOncology #CardioOnc #WilliamsburgVA
A full day of global insights and networking starts at 8am sharp. Grab a coffee and get acquainted with the schedule 👇
📰 gcos.ic-os.org/GCOS26Program
#CardioOncology #CardioOnc #WilliamsburgVA
Late morning kicks off with a discussion on how AI is changing cardio-oncology – followed by the year's best research. Then it's lunch and a tour of the product theatre with sponsor @AstraZeneca.
📰 gcos.ic-os.org/GCOS26Program
#CardioOncology #CardioOnc #AI
Late morning kicks off with a discussion on how AI is changing cardio-oncology – followed by the year's best research. Then it's lunch and a tour of the product theatre with sponsor @AstraZeneca.
📰 gcos.ic-os.org/GCOS26Program
#CardioOncology #CardioOnc #AI
Share your favorite moments throughout the day with #GCOS26
#CardioOnc #CardioOncology
Share your favorite moments throughout the day with #GCOS26
#CardioOnc #CardioOncology
#GCOS26 #HealthcareConference #CardioOnc #CardioOncology
#GCOS26 #HealthcareConference #CardioOnc #CardioOncology
Discover why delayed diagnosis is costing lives & how new treatment paradigms are rewriting the rules with Dr. María Juliana Rodríguez G. at #ACCLATAM this Friday!
Details: https://bit.ly/46nD2dU
#ACCIntl #CardioOnc
Discover why delayed diagnosis is costing lives & how new treatment paradigms are rewriting the rules with Dr. María Juliana Rodríguez G. at #ACCLATAM this Friday!
Details: https://bit.ly/46nD2dU
#ACCIntl #CardioOnc
🎟️ Register: tinyurl.com/yesvs987
#CardioOnc #GlobalHealth
🎟️ Register: tinyurl.com/yesvs987
#CardioOnc #GlobalHealth
Consultant Cardiologist at SSMC Abu Dhabi, 14+ yrs in heart failure, transplant & cardio-oncology. Leading cardiologist in MENA.
Thank you for all you do, Dr Skouri!
#cardiooncology #cardioonc #heartfailure
Consultant Cardiologist at SSMC Abu Dhabi, 14+ yrs in heart failure, transplant & cardio-oncology. Leading cardiologist in MENA.
Thank you for all you do, Dr Skouri!
#cardiooncology #cardioonc #heartfailure
Join Rudolf de Boer, MD at #GCOS26 to explore cardiotoxicity, shared risk, and coordinated care strategies.
🎟️ Register: tinyurl.com/4s23wrbw
#CardioOnc #HeartFailure #cardiotoxicity
Join Rudolf de Boer, MD at #GCOS26 to explore cardiotoxicity, shared risk, and coordinated care strategies.
🎟️ Register: tinyurl.com/4s23wrbw
#CardioOnc #HeartFailure #cardiotoxicity
Dr Abdelrahmen Ali sits down with Dr Eri Kato 🇯🇵 to discuss #cardiooncology in Asia and #GCOS27.
Tune in: youtu.be/rFCKlrCwsqo
🎟️ Register today for #GCOS26: tinyurl.com/43z9w4y3
#AsiaHealth #HealthcareConference #CardioOnc
Dr Abdelrahmen Ali sits down with Dr Eri Kato 🇯🇵 to discuss #cardiooncology in Asia and #GCOS27.
Tune in: youtu.be/rFCKlrCwsqo
🎟️ Register today for #GCOS26: tinyurl.com/43z9w4y3
#AsiaHealth #HealthcareConference #CardioOnc
Join Anecita Fadol at #GCOS26 as she traces its evolution.
🎟️ tinyurl.com/2muwfyz4
#CardioOnc #Nursing #GCOS
Join Anecita Fadol at #GCOS26 as she traces its evolution.
🎟️ tinyurl.com/2muwfyz4
#CardioOnc #Nursing #GCOS
jacc.org/doi/10.1016/j.…
@AnaBaracCardio @sdent_cardioonc @SarjuGanatraMD @Richardkcheng2 @anita_deswal
jacc.org/doi/10.1016/j.…
@AnaBaracCardio @sdent_cardioonc @SarjuGanatraMD @Richardkcheng2 @anita_deswal
🩸apixaban low 2.5 mg vs full dose 5mg in patients with cancer+VTE: primary endpoint recurrent VTE
🩸more than half female! 👏🏽👏🏽
🩸the low dose was significant for noninferiority for efficacy & ⤵️ bleed
🩸no increase in deaths
🩸apixaban low 2.5 mg vs full dose 5mg in patients with cancer+VTE: primary endpoint recurrent VTE
🩸more than half female! 👏🏽👏🏽
🩸the low dose was significant for noninferiority for efficacy & ⤵️ bleed
🩸no increase in deaths
www.hekahealth.com/aha25
www.hekahealth.com/aha25